X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (56222) 56222
Publication (3703) 3703
Book Review (447) 447
Newsletter (274) 274
Book Chapter (173) 173
Book / eBook (168) 168
Magazine Article (68) 68
Conference Proceeding (51) 51
Dissertation (40) 40
Web Resource (21) 21
Newspaper Article (7) 7
Paper (7) 7
Data Set (6) 6
Trade Publication Article (5) 5
Streaming Video (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50672) 50672
male (29144) 29144
female (26903) 26903
middle aged (23462) 23462
index medicus (21855) 21855
aged (18945) 18945
kidney neoplasms - pathology (17659) 17659
adult (15946) 15946
oncology (13800) 13800
cancer (12522) 12522
carcinoma, renal cell - pathology (12447) 12447
urology & nephrology (10053) 10053
kidney neoplasms - surgery (9549) 9549
renal cell carcinoma (9143) 9143
carcinoma, renal cell - surgery (7636) 7636
carcinoma, renal cell (7259) 7259
prognosis (6945) 6945
tumors (6900) 6900
aged, 80 and over (6746) 6746
renal-cell carcinoma (6679) 6679
nephrectomy (6227) 6227
treatment outcome (6202) 6202
retrospective studies (5958) 5958
kidney neoplasms - drug therapy (5413) 5413
animals (5371) 5371
carcinoma, renal cell - drug therapy (5309) 5309
kidney neoplasms - genetics (5045) 5045
carcinoma, renal cell - secondary (5022) 5022
surgery (5013) 5013
metastasis (4933) 4933
carcinoma, renal cell - genetics (4733) 4733
kidney neoplasms - diagnosis (4531) 4531
care and treatment (4324) 4324
kidney (4244) 4244
pathology (4117) 4117
risk factors (4040) 4040
kidney neoplasms - metabolism (4024) 4024
neoplasm staging (3992) 3992
survival (3951) 3951
carcinoma (3841) 3841
kidney neoplasms - therapy (3835) 3835
kidney neoplasms - mortality (3779) 3779
carcinoma, renal cell - metabolism (3694) 3694
carcinoma, renal cell - diagnosis (3688) 3688
immunohistochemistry (3599) 3599
kidney neoplasms - diagnostic imaging (3556) 3556
tomography, x-ray computed (3540) 3540
carcinoma, renal cell - mortality (3511) 3511
research (3457) 3457
urology (3405) 3405
nephrectomy - methods (3379) 3379
carcinoma, renal cell - therapy (3348) 3348
expression (3313) 3313
analysis (3285) 3285
diagnosis (3270) 3270
antineoplastic agents - therapeutic use (3264) 3264
diagnosis, differential (3257) 3257
follow-up studies (3184) 3184
kidney cancer (2973) 2973
adolescent (2913) 2913
neoplasm metastasis (2755) 2755
medicine & public health (2663) 2663
mice (2626) 2626
radiology, nuclear medicine & medical imaging (2605) 2605
survival rate (2596) 2596
health aspects (2545) 2545
time factors (2458) 2458
kidney neoplasms - complications (2431) 2431
cell line, tumor (2424) 2424
therapy (2402) 2402
carcinoma, renal cell - diagnostic imaging (2340) 2340
immunotherapy (2289) 2289
kidney neoplasms (2277) 2277
cell carcinoma (2185) 2185
neoplasms (2163) 2163
child (2079) 2079
survival analysis (2078) 2078
chemotherapy (2055) 2055
kidney - pathology (2031) 2031
disease-free survival (2022) 2022
abridged index medicus (2007) 2007
sunitinib (1945) 1945
young adult (1930) 1930
kidneys (1896) 1896
interferon-alpha (1861) 1861
article (1851) 1851
cell biology (1782) 1782
management (1755) 1755
gene expression regulation, neoplastic (1727) 1727
kidney transplantation (1714) 1714
medicine, general & internal (1711) 1711
patients (1702) 1702
urologic and male genital diseases (1697) 1697
pharmacology & pharmacy (1668) 1668
carcinoma, renal cell - complications (1661) 1661
radical nephrectomy (1661) 1661
development and progression (1660) 1660
transplantation (1651) 1651
magnetic resonance imaging (1642) 1642
medicine (1634) 1634
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (115) 115
Online Resources - Online (12) 12
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Humber River Regional Hospital - Church Stacks (5) 5
Scarborough Hospital - General (5) 5
St. Michael's Hospital - Stacks (4) 4
Humber River Regional Hospital - Finch Stacks (3) 3
Scarborough Hospital - Birchmount (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Toronto East General Hospital - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Knox College (Caven) - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Grace (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Wycliffe Storage (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50397) 50397
Japanese (1684) 1684
German (1423) 1423
French (1083) 1083
Spanish (707) 707
Chinese (390) 390
Russian (365) 365
Italian (276) 276
Polish (126) 126
Czech (63) 63
Dutch (58) 58
Portuguese (54) 54
Turkish (51) 51
Korean (43) 43
Hungarian (41) 41
Bulgarian (28) 28
Danish (28) 28
Romanian (25) 25
Croatian (22) 22
Serbian (22) 22
Hebrew (11) 11
Norwegian (11) 11
Arabic (10) 10
Swedish (10) 10
Ukrainian (7) 7
Slovak (6) 6
Finnish (5) 5
Icelandic (5) 5
Bosnian (3) 3
Latvian (3) 3
Lithuanian (3) 3
Afrikaans (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japanese Journal of Clinical Oncology, ISSN 0368-2811, 06/2016, Volume 46, Issue 6, pp. 497 - 501
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 1, pp. 93 - 105
Abstract The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO “blue book”), published in 2016, contains... 
Urology | Urogenital tract | WHO classification | Male genital organs | SQUAMOUS-CELL-CARCINOMA | TUBULOCYSTIC CARCINOMA | DIFFERENTIATED PAPILLARY MESOTHELIOMA | SPERMATOCYTIC SEMINOMA | PRIMARY PURE TERATOMA | GERM-CELLS | UROLOGY & NEPHROLOGY | GONADAL STROMAL TUMOR | YOLK-SAC TUMOR | IN-SITU | CLINICOPATHOLOGICAL FEATURES | Neoplastic Syndromes, Hereditary - pathology | Uterine Neoplasms - pathology | Carcinoma, Squamous Cell - virology | Humans | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Male | Testicular Neoplasms - pathology | Neoplasm Grading | Leiomyomatosis - pathology | Carcinoma, Renal Cell - enzymology | Uterine Neoplasms - classification | Testicular Neoplasms - classification | Skin Neoplasms - pathology | Penile Neoplasms - virology | Papillomavirus Infections - complications | World Health Organization | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Leiomyomatosis - classification | Succinate Dehydrogenase - deficiency | Skin Neoplasms - classification | Carcinoma, Squamous Cell - classification | Neoplasms, Germ Cell and Embryonal - classification | Kidney Neoplasms - pathology | Penile Neoplasms - classification | Neoplastic Syndromes, Hereditary - classification | Neoplasms, Germ Cell and Embryonal - pathology | Medical colleges | Squamous cell carcinoma | Papillomavirus infections | Tumors
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2017, Volume 117, Issue 5, pp. 752 - 755
Background: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent.... 
kidney cancer | renal cell carcinoma | ONCOLOGY | survival | RISK | DYSFUNCTION | blood | prognosis | CANCER | telomere length | PREDISPOSITION FACTOR | Kidney Neoplasms - genetics | Prognosis | Telomere - ultrastructure | Kidney Neoplasms - ultrastructure | Lung Neoplasms - mortality | Colorectal Neoplasms - genetics | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Ovarian Neoplasms - mortality | Case-Control Studies | Kidney Neoplasms - blood | Carcinoma, Renal Cell - ultrastructure | Ovarian Neoplasms - genetics | Telomere Shortening | Prostatic Neoplasms - genetics | Prostatic Neoplasms - blood | Female | Colorectal Neoplasms - mortality | Lung Neoplasms - genetics | Carcinoma, Renal Cell - blood | Colorectal Neoplasms - blood | Ovarian Neoplasms - blood | Survival Rate | Kidney Neoplasms - mortality | Prostatic Neoplasms - mortality | Biomarkers, Tumor - blood | Ovarian Neoplasms - ultrastructure | Carcinoma, Renal Cell - mortality | Leukocytes - ultrastructure | Prostatic Neoplasms - ultrastructure | Colorectal Neoplasms - ultrastructure | Lung Neoplasms - ultrastructure | Aged | Biomarkers, Tumor - genetics | Lung Neoplasms - blood | Cell survival | Ovarian carcinoma | Lung cancer | Medical screening | Survival | Ovarian cancer | Polymerase chain reaction | Confidence intervals | Medical prognosis | Biomarkers | Bioindicators | Health risk assessment | Prostate | Clear cell-type renal cell carcinoma | Cancer | Kidney transplantation | Epidemiology
Journal Article
Journal Article
INTERNATIONAL JOURNAL OF CANCER, ISSN 0020-7136, 02/2001, Volume 91, Issue 3, pp. 421 - 430
Journal Article
Head & Neck, ISSN 1043-3074, 12/2016, Volume 38, Issue 12, pp. 1847 - 1854
The sinonasal cavities are rare locations for metastases. Metastases to these locations are usually solitary and produce similar symptoms to those of a primary... 
sinonasal cavities | metastases | maxillary sinus | paranasal sinuses | nasal cavity | SURGERY | HEAD | SKULL-BASE | MAXILLARY METASTASIS | SPHENOID SINUS | UNKNOWN PRIMARY | RENAL-CELL CARCINOMA | RADIATION-THERAPY | SINONASAL | HEPATOCELLULAR-CARCINOMA | OTORHINOLARYNGOLOGY | FOLLICULAR THYROID-CARCINOMA | Bone Neoplasms - mortality | Prognosis | Bone Neoplasms - therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Bone Neoplasms - pathology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Thyroid Neoplasms - therapy | Nasal Cavity - pathology | Female | Liver Neoplasms - pathology | Kidney Neoplasms - therapy | Paranasal Sinus Neoplasms - therapy | Prostatic Neoplasms - pathology | Thyroid Neoplasms - mortality | Risk Assessment | Carcinoma, Renal Cell - pathology | Lung Neoplasms - therapy | Kidney Neoplasms - mortality | Maxillary Sinus Neoplasms - mortality | Prostatic Neoplasms - mortality | Paranasal Sinus Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Breast Neoplasms - pathology | Survival Analysis | Carcinoma, Renal Cell - therapy | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Paranasal Sinus Neoplasms - secondary | Maxillary Sinus Neoplasms - therapy | Maxillary Sinus Neoplasms - secondary | Thyroid Neoplasms - pathology | Radiotherapy | Metastasis
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 8/2007, Volume 56, Issue 8, pp. 1173 - 1182
The programmed death-1 (PD-1)/B7-H1 (also called PD-L1) pathway negatively regulates T cell activation and has been suggested to play an important role in... 
Urothelial cancer | Biomedicine | Immunology | B7-H1/PD-L1 | Costimulation | T cell | Oncology | Cancer Research | Antitumor immunity | PD-1 | BLADDER-CANCER | DENDRITIC CELLS | PROGRAMMED DEATH-1 | urothelial cancer | TISSUE INFILTRATING LYMPHOCYTES | IMMUNOLOGY | antitumor immunity | POTENTIAL MECHANISM | RENAL-CELL CARCINOMA | CD8(+) T-CELLS | costimulation | ONCOLOGY | PD-L1 | B7 FAMILY | B7-H1 | EXPRESSION | Carcinoma, Transitional Cell - mortality | Prognosis | Antigens, CD - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Kidney Pelvis - chemistry | Ureteral Neoplasms - pathology | Male | Kidney Neoplasms - chemistry | Antigens, CD - genetics | Antigens, CD - analysis | Kidney Neoplasms - surgery | Urinary Bladder Neoplasms - pathology | Female | Neoplasm Proteins - genetics | Kidney Pelvis - surgery | Urinary Bladder Neoplasms - mortality | B7-H1 Antigen | Neoplasm Proteins - biosynthesis | Ureteral Neoplasms - chemistry | Neoplasm Recurrence, Local | Proportional Hazards Models | Kidney Pelvis - pathology | Immunophenotyping | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - chemistry | Survival Analysis | Antigens, CD - physiology | Kidney Neoplasms - pathology | Neoplasm Proteins - analysis | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Lymphocytes, Tumor-Infiltrating - immunology | Cancer
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
World Journal of Urology, ISSN 0724-4983, 4/2014, Volume 32, Issue 2, pp. 475 - 479
Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and... 
Nephrology | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Urothelial carcinoma | Waiting time | Survival | Prostate cancer | BLADDER-CANCER | SMALL RENAL MASSES | MANAGEMENT | RADICAL PROSTATECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | CYSTECTOMY | QUALITY-OF-LIFE | DELAY | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Prostatectomy - methods | Testicular Neoplasms - mortality | Urologic Neoplasms - diagnosis | Urinary Bladder Neoplasms - diagnosis | Humans | Carcinoma, Renal Cell - surgery | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - diagnosis | Nephrectomy - methods | Kidney Neoplasms - diagnosis | Testicular Neoplasms - surgery | Kidney Neoplasms - surgery | Time Factors | Neoplasms, Germ Cell and Embryonal - mortality | Penile Neoplasms - mortality | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Prostatic Neoplasms - surgery | Time-to-Treatment | Urologic Neoplasms - mortality | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Prostatic Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Penile Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Ureteral Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - surgery | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Cystectomy - methods | Orchiectomy - methods | Urologic Neoplasms - surgery | Diagnosis | Health aspects | Tumors
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 02/2017, Volume 125, Issue 2, pp. 91 - 103
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 2014, Volume 21, Issue 1, pp. 106 - 113
Kidney transplant recipients are at increased risk for development of malignancy compared with the general population, and malignancies occur at an earlier... 
Nephrology | Immunosuppression | Malignancy | Kidney transplant | Cancer screening | AZATHIOPRINE | RISK | CERVICAL-CANCER | HUMAN-PAPILLOMAVIRUS | RECIPIENTS | CIGARETTE-SMOKING | NONMELANOMA SKIN-CANCER | UROLOGY & NEPHROLOGY | MALIGNANCIES | IMMUNOSUPPRESSIVE DRUGS | EPSTEIN-BARR-VIRUS | Kidney Neoplasms - epidemiology | Breast Neoplasms - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Kidney Neoplasms - immunology | Lymphoproliferative Disorders - immunology | Neoplasms - diagnosis | Kidney Transplantation - statistics & numerical data | Carcinoma, Renal Cell - immunology | Colorectal Neoplasms - diagnosis | Kidney Neoplasms - diagnosis | Skin Neoplasms - diagnosis | Female | Anus Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Kidney Failure, Chronic - surgery | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - immunology | Early Detection of Cancer | Uterine Cervical Neoplasms - immunology | Skin Neoplasms - epidemiology | Lymphoproliferative Disorders - epidemiology | Anus Neoplasms - diagnosis | Carcinoma, Renal Cell - epidemiology | Anus Neoplasms - immunology | Colorectal Neoplasms - immunology | Lymphoproliferative Disorders - diagnosis | Neoplasms - immunology | Carcinoma, Renal Cell - diagnosis | Immunosuppressive Agents - adverse effects | Breast Neoplasms - diagnosis | Immunocompromised Host | Neoplasms - epidemiology
Journal Article